Pancreatic cancer statistics

Cases

New cases of pancreatic cancer, 2015, UK

Deaths

Deaths from pancreatic cancer, 2016, UK

Survival

Survive pancreatic cancer for 10 or more years, 2010-11, England and Wales

Prevention

Preventable cases of pancreatic cancer, UK

  • There are around 9,800 new pancreatic cancer cases in the UK every year, that's 27 every day (2013-2015).
  • Pancreatic cancer is the 11th most common cancer in the UK, accounting for 3% of all new cancer cases (2015).
  • In males in the UK, pancreatic cancer is the 12th most common cancer, with around 5,000 new cases in 2015.
  • In females in the UK, pancreatic cancer is the 9th most common cancer, with around 5,000 new cases in 2015.
  • Incidence rates for pancreatic cancer in the UK are highest in people aged 85 to 89 (2013-2015).
  • Since the early 1990s, pancreatic cancer incidence rates have increased by around a seventh (15%) in the UK. Rates in males have increased by around a tenth (9%), and rates in females have increased by a sixth (17%).
  • Over the last decade, pancreatic cancer incidence rates have increased by around a tenth (11%) in the UK. Rates in males have increased by around a tenth (9%), and rates in females have increased by around a tenth (11%).
  • Around 8 in 10 pancreatic cancer cases are diagnosed at a late stage in England (2014) Scotland (2014).
  • Incidence rates for pancreatic cancer are projected to rise by 6% in the UK between 2014 and 2035, to 21 cases per 100,000 people by 2035.
  • Pancreatic cancer in England is more common in people living in the most deprived areas.
  • Pancreatic cancer is more common in White and Black people than in Asian people.
  • An estimated 6,600 people who had previously been diagnosed with pancreatic cancer were alive in the UK at the end of 2010.

See more in-depth pancreatic cancer incidence statistics

  • There are around 9,000 pancreatic cancer deaths in the UK every year, that's 25 every day (2014-2016).
  • Pancreatic cancer is the 6th most common cause of cancer death in the UK, accounting for 6% of all cancer deaths (2016).
  • In males in the UK, pancreatic cancer is the 5th most common cause of cancer death, with around 4,700 deaths in 2016.
  • In females in the UK, pancreatic cancer is the 5th most common cause of cancer death, with around 4,500 deaths in 2016.
  • Mortality rates for pancreatic cancer in the UK are highest in people aged 85 to 89 (2014-2016).
  • Since the early 1970s, pancreatic cancer mortality rates have remained stable in the UK. Rates in males have decreased by around a seventh (13%), and rates in females have increased by around a tenth (11%).
  • Over the last decade, pancreatic cancer mortality rates have increased by around a twentieth (6%) in the UK. Rates in males have increased by around a twentieth (6%), and rates in females have increased by around a twentieth (6%).
  • Mortality rates for pancreatic cancer are projected to fall by 3% in the UK between 2014 and 2035, to 17 deaths per 100,000 people by 2035
  • Pancreatic cancer deaths in England are more common in people living in the most deprived areas.

See more in-depth pancreatic cancer mortality statistics

  • Only 1% of people diagnosed with pancreatic cancer in England and Wales survive their disease for ten years or more (2010-11).
  • Less than 5 in 100 (3%) of people diagnosed with pancreatic cancer in England and Wales survive their disease for five years or more (2010-11).
  • Around a fifth (21%) of people diagnosed with pancreatic cancer in England and Wales survive their disease for one year or more (2010-11).
  • Pancreatic cancer survival is similar in men than women.
  • Pancreatic cancer survival in England is higher for people diagnosed aged under 50 years old (2009-2013).
  • More than 3 in 20 men and around a quarter of women in England diagnosed with pancreatic cancer aged 15-49 survive their disease for five years or more, compared with only 2% of people diagnosed aged 80 and over (2009-2013).
  • Pancreatic cancer survival has not shown much improvement in the last 40 years in the UK.
  • In the 1970s, 1% of people diagnosed with pancreatic cancer survived their disease beyond ten years, now it's still 1%.
  • Five-year relative survival for pancreatic cancer in men is below the European average in England, Wales, Scotland and Northern Ireland.
  • Five-year relative survival for pancreatic cancer in women is below the European average in England but similar to the European average in Wales.

See more in-depth pancreatic cancer survival statistics

  • A person’s risk of developing cancer depends on many factors, including age, genetics, and exposure to risk factors (including some potentially avoidable lifestyle factors).
  • 1 in 53 UK males and 1 in 57 UK females will be diagnosed with pancreatic cancer in their lifetime.
  • 31% of pancreatic cancer cases in the UK are preventable.

See more in-depth pancreatic cancer risk statistics

  • 'Emergency presentation' is the most common route to diagnosing pancreatic cancer.
  • ‘Two-week wait’ standards are met by all countries, ‘31-day wait’ is met by all but Northern Ireland, and ‘62-day wait’ is not met by any country for upper gastrointestinal cancers.
  • 10% of patients diagnosed with pancreatic cancer have surgery to remove the tumour as part of their primary cancer treatment.
  • 5% of patients diagnosed with pancreatic cancer have radiotherapy as part of their primary cancer treatment.
  • 28% of patients diagnosed with pancreatic cancer have chemotherapy as part of their primary cancer treatment.

See more in-depth pancreatic cancer diagnosis and treatment statistics

Want the key stats in the sections on this page as a document? or looking for a stats report of the in-depth stats? Use the print function at the bottom of any Cancer Stats page Share this page > Print or your browser options to print or save.

The latest statistics available for pancreatic cancer in the UK are; incidence 2015, mortality 2016 and survival 2010-2011 (all ages combined) and 2009-2013 (by age).

The ICD code Open a glossary item for pancreatic cancer is ICD-10 C25.

European Age-Standardised Rates were calculated using the 1976 European Standard Population (ESP) unless otherwise stated as calculated with ESP2013. ASRs calculated with ESP2013 are not comparable with ASRs calculated with ESP1976.

Survival statistics give an overall picture of survival and (unless otherwise stated) include all adults (15-99) diagnosed, at all ages, stages Open a glossary item and co-morbidities Open a glossary item. The survival time experienced by an individual patient may be much higher or lower, depending on specific patient and tumour characteristics.

Meta-analyses Open a glossary item and systematic reviews Open a glossary item are cited where available, as they provide the best overview of all available research and most take study quality into account. Individual case-control and cohort studies Open a glossary item are reported where such aggregated data are lacking.

Routes to diagnosis statistics were calculated from cases of cancer registered in England which were diagnosed in 2012-2013.

Cancer waiting times statistics are for patients who entered the health care system within financial year 2014-15. Pancreatic cancer is part of the group 'Upper Gastrointestinal cancer' for cancer waiting times data. Codes vary per country but broadly include: oesophagus, stomach, liver, gallbladder, other and unspecified parts of biliary tract, pancreas, secondary cancers of liver, intrahepatic bile duct and duodenum.

Cancer surgical resection rates data is for patients diagnosed in England between 2006 and 2010.

Patient Experience data is for adult patients in England with a primary diagnosis of cancer, who were in active treatment between September and November 2013 and who completed a survey in 2014.

Deprivation gradient statistics were calculated using incidence data for three time periods: 1996-2000, 2001-2005 and 2006-2010 and for mortality for two time periods: 2002-2006 and 2007-2011. The 1997-2001 mortality data were only used for the all cancers combined group as this time period includes the change in coding from ICD-9 to ICD-10. The deprivation quintiles were calculated using the Income domain scores from the Index of Multiple Deprivation (IMD) from the following years: 2004, 2007 and 2010. Full details on the data and methodology can be found in the Cancer by Deprivation in England NCIN report.

Last reviewed:

Citation

You are welcome to reuse this Cancer Research UK content for your own work.
Credit us as authors by referencing Cancer Research UK as the primary source. Suggested styles are:

Web content: Cancer Research UK, full URL of the page, Accessed [month] [year].
Publications: Cancer Research UK ([year of publication]), Name of publication, Cancer Research UK.
Graphics (when reused unaltered): Credit: Cancer Research UK.
Graphics (when recreated with differences): Based on a graphic created by Cancer Research UK.

When Cancer Research UK material is used for commercial reasons, we encourage a donation to our life-saving research.
Send a cheque payable to Cancer Research UK to: Cancer Research UK, Angel Building, 407 St John Street, London, EC1V 4AD or

Donate online

Acknowledgements

We are grateful to the many organisations across the UK which collect, analyse, and share the data which we use, and to the patients and public who consent for their data to be used. Find out more about the sources which are essential for our statistics.

Rate this page:

Currently rated: 3.6 out of 5 based on 36 votes
Thank you!
We've recently made some changes to the site, tell us what you think